Tisotumab vedotin by Genmab for Metastatic Colorectal Cancer

Tisotumab vedotin is under clinical development by Genmab and currently in Phase II for Metastatic Colorectal Cancer.

Related Keywords

Copenhagen , Køavn , Denmark , Japan , Netherlands , Tisotumab Vedotin Tivdak , Tisotumab Vedotin , Globaldata Pharmaceutical Intelligence Center , Metastatic Colorectal , Metastatic Colorectal Cancer , Phase Transition Success Rate Model , Tissue Factor , Pharmaceutical Intelligence ,